Alqudah A, Qnais E, Wedyan M, Awali A, Bseiso Y, Gammoh O
Mol Biol Rep. 2024; 51(1):200.
PMID: 38270677
DOI: 10.1007/s11033-023-09107-8.
Rabelo F, Lemos I, Dal Toe C, Casagrande D, Freitas M, Quadra M
Metab Brain Dis. 2023; 38(5):1573-1579.
PMID: 36897514
DOI: 10.1007/s11011-023-01193-8.
Conway M
Biogerontology. 2020; 21(3):257-274.
PMID: 32048098
PMC: 7196085.
DOI: 10.1007/s10522-020-09860-4.
Neinast M, Murashige D, Arany Z
Annu Rev Physiol. 2018; 81:139-164.
PMID: 30485760
PMC: 6536377.
DOI: 10.1146/annurev-physiol-020518-114455.
Scaini G, Tonon T, de Souza C, Schuck P, Ferreira G, Quevedo J
J Inherit Metab Dis. 2018; .
PMID: 29740775
DOI: 10.1007/s10545-018-0188-x.
Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.
Taschetto L, Scaini G, Zapelini H, Ramos A, Strapazzon G, Andrade V
Metab Brain Dis. 2017; 32(5):1507-1518.
PMID: 28550500
DOI: 10.1007/s11011-017-0035-z.
Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.
Burrage L, Nagamani S, Campeau P, Lee B
Hum Mol Genet. 2014; 23(R1):R1-8.
PMID: 24651065
PMC: 4170715.
DOI: 10.1093/hmg/ddu123.
Effect of leucine administration to female rats during pregnancy and lactation on oxidative stress and enzymes activities of phosphoryltransfer network in cerebral cortex and hippocampus of the offspring.
de Franceschi I, Rieger E, Vargas A, Rojas D, Campos A, Rech V
Neurochem Res. 2013; 38(3):632-43.
PMID: 23277415
DOI: 10.1007/s11064-012-0961-4.
Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy.
Zinnanti W, Lazovic J
J Inherit Metab Dis. 2011; 35(1):71-9.
PMID: 21541722
DOI: 10.1007/s10545-011-9333-5.
Aminoaciduria and lens opacity formation.
McGuinness R, Saunders R
Br J Ophthalmol. 1968; 52(1):40-2.
PMID: 18170888
PMC: 506520.
DOI: 10.1136/bjo.52.1.40.
[MAPLE SYRUP DISEASE WITH FAMILIAL INCIDENCE].
DIEZEL P, Martin K
Virchows Arch Pathol Anat Physiol Klin Med. 1964; 337:425-45.
PMID: 14217031
HYPERGLYCINAEMIA AND HYPERGLYCINURIA IN A NEWBORN INFANT.
Visser H, VEENSTRA H, PIK C
Arch Dis Child. 1964; 39:397-402.
PMID: 14206882
PMC: 2019318.
DOI: 10.1136/adc.39.206.397.
DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
WESTALL R
Arch Dis Child. 1963; 38:485-91.
PMID: 14065992
PMC: 2019098.
DOI: 10.1136/adc.38.201.485.
Recent work on phenylketonuria and maple syrup urine disease (leucinosis).
WOOLF L
Proc R Soc Med. 1962; 55:824-6.
PMID: 14001839
PMC: 1896858.
Maple syrup urine disease.
PATRICK A
Arch Dis Child. 1961; 36:269-72.
PMID: 13733337
PMC: 2012762.
DOI: 10.1136/adc.36.187.269.
Studies in maple syrup urine disease.
DENT C, WESTALL R
Arch Dis Child. 1961; 36:259-68.
PMID: 13721928
PMC: 2012780.
DOI: 10.1136/adc.36.187.259.
Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
Pilla C, Cardozo R, Dutra-Filho C, Wyse A, Wajner M, Duval Wannmacher C
Neurochem Res. 2003; 28(5):675-9.
PMID: 12716015
DOI: 10.1023/a:1022876130038.
Effect of leucine administration on creatine kinase activity in rat brain.
Pilla C, Cardozo R, Dutra-Filho C, Wyse A, Wajner M, Duval Wannmacher C
Metab Brain Dis. 2003; 18(1):17-25.
PMID: 12603079
DOI: 10.1023/a:1021974517837.
Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
Schadewaldt P, Hammen H, Ott A, Wendel U
J Inherit Metab Dis. 1999; 22(6):706-22.
PMID: 10472531
DOI: 10.1023/a:1005540016376.
Maple syrup urine disease 1954 to 1993.
Peinemann F, Danner D
J Inherit Metab Dis. 1994; 17(1):3-15.
PMID: 8051937
DOI: 10.1007/BF00735389.
